|
| 6-BROMO-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE Basic information |
Product Name: | 6-BROMO-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE | Synonyms: | 6-BROMO-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE;6-BROMO-3,4-1(1H)-ISOQUINOLINONE;6-BROMO-3,4-DIHYDRO-1(1H)-ISOQUINOLINONE;6-BROMO-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ON;1(2H)-Isoquinolinone, 6-bromo-3,4-dihydro-;6-Bromo-3,4-dihydro-1(2H)-isoquinolinone;6-BroMo-1-oxo-1,2,3,4-tetrahydroisoquinoline;6-broMo-1,2,3,4-tetrahydroisoquinolin-1-one | CAS: | 147497-32-3 | MF: | C9H8BrNO | MW: | 226.07 | EINECS: | | Product Categories: | Amines;Aromatics;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals | Mol File: | 147497-32-3.mol | |
| 6-BROMO-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE Chemical Properties |
Melting point | 170.0-173.1 °C | Boiling point | 453.3±45.0 °C(Predicted) | density | 1.559±0.06 g/cm3(Predicted) | storage temp. | Sealed in dry,Room Temperature | form | powder | pka | 14.22±0.20(Predicted) | color | Yellow |
| 6-BROMO-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE Usage And Synthesis |
Uses | 6-bromo-3,4-dihydroisoquinolin-1(2H)-one is an intermediate used in the synthesis of benzolactams as dopamine D3 receptor ligands.IT is also used in the synthesis of new, selective 3-aminopyrazole based MK2-inhibitors that was proved to inhibit intracellular phosphorylation of hsp27 as well as LPS-induced TNFα release in cells. |
| 6-BROMO-3,4-DIHYDRO-2H-ISOQUINOLIN-1-ONE Preparation Products And Raw materials |
|